A Placebo-Controlled, Double-Blind, Parallel-Group, Randomized, Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Subjects With Dementia With Lewy Bodies

Grants and Contracts Details

StatusFinished
Effective start/end date8/24/184/10/21

Funding

  • Eisai Incorporated: $181,287.00